Since the initial introduction of sinus dilation, a number of clinical studies have explored its safety, effectiveness, durability, and patient benefits. Data from these studies show that, for appropriate patients, sinus dilation has a low complication rate (0.1% complication rate across 8 studies representing approximately 900 patients) and delivers significant, lasting symptom improvement. To better understand sinus dilation’s role in treatment, many physicians sought a direct comparison of balloon sinus dilation to the current standard of care, functional endoscopic sinus surgery. Outcomes from the first prospective, multi-center,
randomized controlled trial with sufficient statistical power to compare sinus dilation to functional endoscopic sinus surgery were published in the
American Journal of Rhinology & Allergy in 2013 and 2014. Data from the study shows that balloon sinus dilation is as effective as functional sinus surgery, and delivers a better patient recovery experience. Balloon and surgical patients experienced a similar, significant level of: • symptom improvement • decline in number of rhinosinusitis episodes requiring medication in year after treatment • improvements in work productivity and activity level Patients who had balloon sinus dilation experienced a much quicker recovery, less bleeding, and less need for prescription pain medication. Overall, data from these studies address key clinical questions, and affirm sinus dilation’s role as an alternative to traditional surgery. ==Benefits==